My Passport
News and Commentary education Live Coronavirus Dashboard
S&P 500 ETF
0.00%
NASDAQ ETF
0.00%
Dow Jones ETF
0.00%


Shell Strikes $16 Billion Mega-Deal To Conque...
Nvidia's $20 Trillion Path Just Hit A 2026 Pr...
General Motors Q1 Preview: 60% Stock Rally Me...
The Oil World Is Splintering — And America Ha...
'Publicly Closed The Door': United CEO Says A...
Verizon CEO Claims Turnaround Is Officially U...
Peloton's Spotify Partnership Opens Global Ac...
Domino's Hit By Budget-Conscious Diners, Shar...
The Rise of the Solo General Partner Investor

While modern day venture capital originated in the 1940s, the very first iteration of venture capital (VC) investments--where a general partner (GP) investments capital on behalf of a limited partner (LP)--dates all the way back to the early 1600s with the founding of East India...

  • How are Higher Rates Impacting the Housi...
  • Quantitative Tightening: How the Fed Co...
  • Should Investors Worry About Inflation?
  • How Semiconductors are Made and Why its...
  • What Are NFTs?
    • Inflation: What is it and How to Protect From...
    Short Squeezes Could Lead to Market Dislocati...
    How Google and Facebook Antitrust Lawsuits Co...
    Vaccine News Triggers Growth to Value Rotatio...
    Energy
    Materials
    Industrial
    Finance
    Consumer D...
    Consumer S...
    Informatio...
    Telecommun...
    Health Car...
    Utilities
    Oil
    Gold
    ETFs IPOs Ratings
     
    S&P 500 ETF
    0.00%
    NASDAQ ETF
    0.00%
    Dow Jones ETF
    0.00%
    Search
    News and Commentary
    Education
    Market
    ETFs
    IPOs
    Ratings
    Newsfeed
    My passport
    Login
    Sign up

    DIAMEDICA THERAPEUTICS INC (NASDAQ: DMAC)

    Overview
    current price
    $6.25
    $6.25
    change
    -0.07 | -1.11%
    -0.07 | -1.11%
    Yesterday's Close
    6.32
    open
    6.28
    volume
    0.02 M
    30d. avg volume.
    0.22 M
    1 day
    6.23 - 6.35
    52 weeks
    3.48 - 10.42
    p/e
    0.00
    beta
    1.1596
    market cap
    0.34 B
    dividend yield
    0.00%
    Industry
    -
    DMAC by TradingView
    News and Commentary
    4 IPOs on the Schedule, But More Could Follow There are a total of four IPO's on the schedule this week. Most of them are focused in the biotech sector and one is a China-based fashion website. There are a few names becoming...
    Last Call for IPOs in 2018 Following the shortened Thanksgiving week here in the states, there's potentially only one IPO that could launch. As the year nears its end, the clock is ticking for any names th...
    StockTwits
    StockTwits
    Most Shared
    IBM AI Success Faces Macro Headwinds: Analyst Cuts Price Target
    SpaceX IPO Would Test A Brutal Truth: Most IPOs Since 2021 Destroyed Value
    US Economy Stays Resilient, But 'Significant Risks' Are Building Fast, Jamie Dimon Warns
    Most Popular
    AMD Says Space Needs Smarter Chips Now And It's Ready To Deliver
    States Are Spending Millions To Rewire Medicaid, SNAP Systems As Trump's New Law Could Push Millions Off Coverage: Report
    SpaceX IPO Would Test A Brutal Truth: Most IPOs Since 2021 Destroyed Value
    popular tags
    Earnings
    Apple
    Amazon
    Coronavirus
    Coronavirus Impact
    Tesla
    Google
    China
    Covid-19
    mobile iOS
    social Facebook Twitter Youtube Linkedin Rss Google News
    Passport to Wall Street About Us Contact Advertise Privacy Policy Terms of Service
    Sign Up
    © 2026 Passport to Wall Street
    Quotes are at least 20 minutes delayed

    Join now and unlock premium features

    Already Have An Account?